Main > ONCOLOGY (**) > Bladder Cancer>mUC *** > Treatment > JP/USA. AS. Nectin-4 MAb - MonoMe>

---

JP/USA. AS. Nectin-4 MAb - MonoMe>'s subsections
(*) CA Launch Date: 2022. 01.25
(*) JP Approval Date: 2021. 09.27
(*) USA Approval Date: 2019. 12.18.
>Auristatin E ADC Inj. IV Use
>Received PD-1/L1 Inh.+Pt CT
Companies
GN>MonoMe Auristatin E: Vedotin
GN>Nectin-4 MAb: EnfortuMAb
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 6
Patent>UpDate: 2021. 09.28.
RTM
RTM Web-Site

JP/USA. AS. Nectin-4 MAb - MonoMe>'s products
This section has no products